Nucleotide Market Size, Share & Trends Analysis Report by Product (Deoxy Nucleotides), Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), Application, and Region with Growth Forecasts, 2025-2030

The Nucleotide Market was valued at USD 928.2 million in 2024, and is projected to reach USD 1.52 billion by 2030, rising at a CAGR of 8.60%. The global nucleotide market is expected to witness substantial growth over the forecast period owing to its widespread use in pharmaceuticals and food & beverage industries. Diagnostic research along with pharmaceutical applications dominated the nucleotide market owning to properties including enhanced immunity, positive effects on the intestines, and positive effects of recovery from stress. In addition, growing R&D in the field of dietary nucleotide coupled with yeast-derived nucleotide for livestock nutrition across the globe is expected to propel demand over the forecast period.

Nucleotide Market Report Highlights

The TaqMan allelic discrimination segment dominated the global market in 2024, followed by SNP by pyrosequencing
The diagnostics research segment dominated the global market for nucleotides in 2024
The deoxy nucleotides (dNTPs) segment dominated the global nucleotide market in 2024 with a revenue share of 48.4% and is furthermore likely to expand with the fastest CAGR over the forecast period
North America nucleotide market secured the largest market share of 38.9% in 2024 and Europe nucleotide market is set to expand at the fastest-growing CAGR of 8.4% from 2025 to 2030

This report addresses:

Market intelligence to enable effective decision-making.
Market estimates and forecasts from 2018 to 2030.
Growth opportunities and trend analyses.
Segment and regional revenue forecasts for market assessment.
Competition strategy and market share analysis.
Product innovation listings for you to stay ahead of the curve.
COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
Competitive Landscape: Explore the market presence of key players.
Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Nucleotide Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis

Chapter 4. Nucleotide Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Deoxy Nucleotides
4.4.1. Deoxy Nucleotides Market, 2018-2030 (USD Million)
4.4.1.1. Enzyme Sourced
4.4.1.1.1. Enzyme Sourced Nucleotides Market, 2018-2030 (USD Million)
4.4.1.2. Chemical Synthesis
4.4.1.2.1. Chemical Synthesis Nucleotides Market, 2018-2030 (USD Million)
4.5. Dideoxynucleotides
4.5.1. Dideoxynucleotides Market, 2018-2030 (USD Million)
4.6. Nucleotides for RNA Synthesis (rNTP)
4.6.1. Nucleotides for RNA Synthesis (rNTP) Market, 2018-2030 (USD Million)
4.7. Labelled Nucleotides
4.7.1. Labelled Nucleotides Market, 2018-2030 (USD Million)

Chapter 5. Nucleotide Market: Technology Business Analysis

5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. TaqMan Allelic Discrimination
5.4.1. TaqMan Allelic Discrimination Market, 2018-2030 (USD Million)
5.5. Gene Chips & Microarrays
5.5.1. Gene Chips & Microarrays Market, 2018-2030 (USD Million)
5.6. SNP by Pyrosequencing
5.6.1. Gene Chips & Microarrays Market, 2018-2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018-2030 (USD Million)

Chapter 6. Nucleotide Market: Application Business Analysis

6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Pharmaceuticals
6.4.1. Pharmaceuticals Market, 2018-2030 (USD Million)
6.5. Diagnostics Research
6.5.1. Diagnostics Research Market, 2018-2030 (USD Million)
6.6. Food & Beverage Additive
6.6.1. Food & Beverage Additive Market, 2018-2030 (USD Million)
6.7. Animal Feed Additive
6.7.1. Animal Feed Additive Market, 2018-2030 (USD Million)
6.8. Others
6.8.1. Others Market, 2018-2030 (USD Million)

Chapter 7. Nucleotide Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamic
7.4.2.2. Regulatory Framework
7.4.2.3. Competitive Insights
7.4.2.4. U.S. Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamic
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Insights
7.4.3.4. Canada Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamic
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Insights
7.4.4.4. Mexico Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Europe
7.5.1. Europe Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamic
7.5.2.2. Regulatory Framework
7.5.2.3. Competitive Insights
7.5.2.4. UK Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamic
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Insights
7.5.3.4. Germany Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamic
7.5.4.2. Regulatory Framework
7.5.4.3. Competitive Insights
7.5.4.4. France Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamic
7.5.5.2. Regulatory Framework
7.5.5.3. Competitive Insights
7.5.5.4. Italy Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamic
7.5.6.2. Regulatory Framework
7.5.6.3. Competitive Insights
7.5.6.4. Spain Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamic
7.5.7.2. Regulatory Framework
7.5.7.3. Competitive Insights
7.5.7.4. Denmark Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamic
7.5.8.2. Regulatory Framework
7.5.8.3. Competitive Insights
7.5.8.4. Sweden Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamic
7.5.9.2. Regulatory Framework
7.5.9.3. Competitive Insights
7.5.9.4. Norway Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamic
7.6.2.2. Regulatory Framework
7.6.2.3. Competitive Insights
7.6.2.4. Japan Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamic
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Insights
7.6.3.4. China Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamic
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Insights
7.6.4.4. India Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamic
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Insights
7.6.5.4. Australia Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key Country Dynamic
7.6.6.2. Regulatory Framework
7.6.6.3. Competitive Insights
7.6.6.4. Thailand Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.7. South Korea
7.6.7.1. Key Country Dynamic
7.6.7.2. Regulatory Framework
7.6.7.3. Competitive Insights
7.6.7.4. South Korea Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamic
7.7.2.2. Regulatory Framework
7.7.2.3. Competitive Insights
7.7.2.4. Brazil Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamic
7.7.3.2. Regulatory Framework
7.7.3.3. Competitive Insights
7.7.3.4. Argentina Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamic
7.8.2.2. Regulatory Framework
7.8.2.3. Competitive Insights
7.8.2.4. South Africa Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamic
7.8.3.2. Regulatory Framework
7.8.3.3. Competitive Insights
7.8.3.4. Saudi Arabia Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamic
7.8.4.2. Regulatory Framework
7.8.4.3. Competitive Insights
7.8.4.4. UAE Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamic
7.8.5.2. Regulatory Framework
7.8.5.3. Competitive Insights
7.8.5.4. Kuwait Nucleotide Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. CJ CheilJedang Corp.
8.5.1.1. Participant’s Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Star Lake Bioscience
8.5.2.1. Participant’s Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Thermo Fisher Scientific Inc.
8.5.3.1. Participant’s Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. MEIHUA HOLDINGS GROUP CO., LTD.
8.5.4.1. Participant’s overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. F. Hoffmann-La Roche Ltd.
8.5.5.1. Participant’s Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Biorigin
8.5.6.1. Participant’s Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. DSM
8.5.7.1. Participant’s Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Promega Corporation
8.5.8.1. Participant’s Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Agilent Technologies, Inc.
8.5.9.1. Participant’s Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Lallemand Inc.
8.5.10.1. Participant’s Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Nanjing Biotogether Co., Ltd.
8.5.11.1. Participant’s Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
8.5.12. NuEra Nutraceuticals Inc.
8.5.12.1. Participant’s Overview
8.5.12.2. Financial Performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic Initiatives
8.5.13. Ohly
8.5.13.1. Participant’s Overview
8.5.13.2. Financial Performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic Initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Nucleotide Market, by Region, 2018-2030 (USD Million)
Table 4. Global Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 5. Global Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 6. Global Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 7. North America Nucleotide Market, by Country, 2018-2030 (USD Million)
Table 8. North America Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 9. North America Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 10. North America Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 11. U.S. Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 12. U.S. Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 13. U.S. Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 14. Canada Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 15. Canada Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 16. Canada Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 17. Mexico Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 18. Mexico Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 19. Mexico Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 20. Europe Nucleotide Market, by Country, 2018-2030 (USD Million)
Table 21. Europe Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 22. Europe Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 23. Europe Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 24. UK Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 25. UK Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 26. UK Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 27. Germany Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 28. Germany Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 29. Germany Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 30. France Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 31. France Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 32. France Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 33. Italy Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 34. Italy Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 35. Italy Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 36. Spain Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 37. Spain Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 38. Spain Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 39. Denmark Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 40. Denmark Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 41. Denmark Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 42. Sweden Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 43. Sweden Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 44. Sweden Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 45. Norway Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 46. Norway Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 47. Norway Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 48. Asia Pacific Nucleotide Market, by Country, 2018-2030 (USD Million)
Table 49. Asia Pacific Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 50. Asia Pacific Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 51. Asia Pacific Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 52. Japan Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 53. Japan Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 54. Japan Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 55. China Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 56. China Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 57. China Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 58. India Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 59. India Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 60. India Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 61. Australia Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 62. Australia Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 63. Australia Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 64. Thailand Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 65. Thailand Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 66. Thailand Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 67. South Korea Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 68. South Korea Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 69. South Korea Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 70. Latin America Nucleotide Market, by Country, 2018-2030 (USD Million)
Table 71. Latin America Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 72. Latin America Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 73. Latin America Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 74. Brazil Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 75. Brazil Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 76. Brazil Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 77. Argentina Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 78. Argentina Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 79. Argentina Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 80. Middle East & Africa Nucleotide Market, by Country, 2018-2030 (USD Million)
Table 81. Middle East & Africa Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 82. Middle East & Africa Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 83. Middle East & Africa Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 84. South Africa Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 85. South Africa Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 86. South Africa Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 87. Saudi Arabia Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 88. Saudi Arabia Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 89. Saudi Arabia Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 90. UAE Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 91. UAE Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 92. UAE Nucleotide Market, by Application, 2018-2030 (USD Million)
Table 93. Kuwait Nucleotide Market, by Product, 2018-2030 (USD Million)
Table 94. Kuwait Nucleotide Market, by Technology, 2018-2030 (USD Million)
Table 95. Kuwait Nucleotide Market, by Application, 2018-2030 (USD Million)

List of Figures

Figure 1 Nucleotide Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 Market Formulation & Validation
Figure 8 Market Snapshot
Figure 9 Product and Technology Outlook (USD Million)
Figure 10 Application Outlook (USD Million)
Figure 11 Competitive Landscape
Figure 12 Nucleotide Market Dynamics
Figure 13 Nucleotide Market: Porter’s Five Forces Analysis
Figure 14 Nucleotide Market: PESTLE Analysis
Figure 15 Nucleotide Market: Product Segment Dashboard
Figure 16 Nucleotide Market: Product Market Share Analysis, 2024 & 2030
Figure 17 Deoxy Nucleotides Market, 2018-2030 (USD Million)
Figure 18 Dideoxynucleotides Market, 2018-2030 (USD Million)
Figure 19 Nucleotides for RNA Synthesis (rNTP) Market, 2018-2030 (USD Million)
Figure 20 Labelled Nucleotides Market, 2018-2030 (USD Million)
Figure 21 Nucleotide Market: Technology Segment Dashboard
Figure 22 Nucleotide Market: Technology Market Share Analysis, 2024 & 2030
Figure 23 TaqMan Allelic Discrimination Market, 2018-2030 (USD Million)
Figure 24 Gene Chips & Microarrays Market, 2018-2030 (USD Million)
Figure 25 SNP by Pyrosequencing Market, 2018-2030 (USD Million)
Figure 26 Others Market, 2018-2030 (USD Million)
Figure 27 Nucleotide Market: Application Segment Dashboard
Figure 28 Nucleotide Market: Application Market Share Analysis, 2024 & 2030
Figure 29 Pharmaceuticals Market, 2018-2030 (USD Million)
Figure 30 Diagnostics Research Market, 2018-2030 (USD Million)
Figure 31 Food & Beverage Additive Market, 2018-2030 (USD Million)
Figure 32 Animal Feed Additive Market, 2018-2030 (USD Million)
Figure 33 Others Market, 2018-2030 (USD Million)
Figure 34 Nucleotide Market Revenue, by Region
Figure 35 Regional Marketplace: Key Takeaways
Figure 36 Regional Marketplace: Key Takeaways
Figure 37 North America Nucleotide Market, 2018-2030 (USD Million)
Figure 38 U.S. Country Dynamics
Figure 39 U.S. Nucleotide Market, 2018-2030 (USD Million)
Figure 40 Canada Country Dynamics
Figure 41 Canada Nucleotide Market, 2018-2030 (USD Million)
Figure 42 Mexico Country Dynamics
Figure 43 Mexico Nucleotide Market, 2018-2030 (USD Million)
Figure 44 Europe Nucleotide Market, 2018-2030 (USD Million)
Figure 45 UK Country Dynamics
Figure 46 UK Nucleotide Market, 2018-2030 (USD Million)
Figure 47 Germany Country Dynamics
Figure 48 Germany Nucleotide Market, 2018-2030 (USD Million)
Figure 49 France Country Dynamics
Figure 50 France Nucleotide Market, 2018-2030 (USD Million)
Figure 51 Italy Country Dynamics
Figure 52 Italy Nucleotide Market, 2018-2030 (USD Million)
Figure 53 Spain Country Dynamics
Figure 54 Spain Nucleotide Market, 2018-2030 (USD Million)
Figure 55 Denmark Country Dynamics
Figure 56 Denmark Nucleotide Market, 2018-2030 (USD Million)
Figure 57 Sweden Country Dynamics
Figure 58 Sweden Nucleotide Market, 2018-2030 (USD Million)
Figure 59 Norway Country Dynamics
Figure 60 Norway Nucleotide Market, 2018-2030 (USD Million)
Figure 61 Asia Pacific Nucleotide Market, 2018-2030 (USD Million)
Figure 62 Japan Country Dynamics
Figure 63 Japan Nucleotide Market, 2018-2030 (USD Million)
Figure 64 China Country Dynamics
Figure 65 China Nucleotide Market, 2018-2030 (USD Million)
Figure 66 India Country Dynamics
Figure 67 India Nucleotide Market, 2018-2030 (USD Million)
Figure 68 Australia Country Dynamics
Figure 69 Australia Nucleotide Market, 2018-2030 (USD Million)
Figure 70 Thailand Country Dynamics
Figure 71 Thailand Nucleotide Market, 2018-2030 (USD Million)
Figure 72 South Korea Country Dynamics
Figure 73 South Korea Nucleotide Market, 2018-2030 (USD Million)
Figure 74 Latin America Nucleotide Market, 2018-2030 (USD Million)
Figure 75 Brazil Country Dynamics
Figure 76 Brazil Nucleotide Market, 2018-2030 (USD Million)
Figure 77 Argentina Country Dynamics
Figure 78 Argentina Nucleotide Market, 2018-2030 (USD Million)
Figure 79 Middle East & Africa Nucleotide Market, 2018-2030 (USD Million)
Figure 80 South Africa Country Dynamics
Figure 81 South Africa Nucleotide Market, 2018-2030 (USD Million)
Figure 82 Saudi Arabia Country Dynamics
Figure 83 Saudi Arabia Nucleotide Market, 2018-2030 (USD Million)
Figure 84 UAE Country Dynamics
Figure 85 UAE Nucleotide Market, 2018-2030 (USD Million)
Figure 86 Kuwait Key Country Dynamics
Figure 87 Kuwait Nucleotide Market, 2018-2030 (USD Million)
Figure 88 Company Categorization
Figure 89 Company Market Position Analysis
Figure 90 Strategic Framework

Companies Mentioned

The major companies profiled in this Nucleotide market report include:

CJ CheilJedang Corp.
Star Lake Bioscience
Thermo Fisher Scientific Inc.
MEIHUA HOLDINGS GROUP CO., LTD.
F. Hoffmann-La Roche Ltd.
Biorigin
DSM
Promega Corporation
Agilent Technologies, Inc.
Lallemand Inc.
Nanjing Biotogether Co., Ltd.
NuEra Nutraceuticals Inc.
Ohly

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	120
Published	February 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 928.2 Million
Forecasted Market Value ( USD ) by 2030	$ 1520 Million
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	14

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5656EUR$5,950USD£4,752GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6607EUR$6,950USD£5,551GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8508EUR$8,950USD£7,148GBP

Nucleotide Market Report Highlights

This report addresses:

Why Should You Buy This Report?

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Nucleotides Market by Product Type, Application - Global Forecast 2025-2030

Nucleotides Market Report by Type, Technology, Form, Application, and Region 2025-2033

Food Nucleotide Market Report: Trends, Forecast and Competitive Analysis to 2030

Single Nucleotide Polymorphism Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

2025 Nucleotide Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)